A Study of TG103 Injection in the Management of Non-diabetic Overweight or Obesity
Clinical trial NCT06226090 · COMPLETED
Trial details
- NCT number
- NCT06226090
- Sponsor
- CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-21
- Primary completion
- 2024-09-26
- Enrollment
- 314
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.